Yokogawa leverages ICQ to bring bioreactors to U.S.
Yokogawa Electric has entered into a partnership with Integrated Commissioning and Qualification Consultants (ICQ) in which ICQ will provide consulting and engineering services for the installation, maintenance, qualification, and support of Yokogawa's bioreactor systems and related products in the U.S. Read More
Aridis moves forward with COVID-19 inhaled antibody development
Anti-infective therapies firm Aridis Pharmaceuticals said that it has augmented its inhaled AR-711 monoclonal antibody to COVID-19 with a second monoclonal antibody designed to neutralize newly emerging COVID-19 mutated variants. Read More
FDA releases new guidance for developers of COVID-19 products
The U.S. Food and Drug Administration (FDA) has released new guidance for developers of products for COVID-19 vaccines, therapies, and tests with a particular emphasis on addressing coronavirus variants. Read More
New technique detects unique folding patterns in RNA of SARS-CoV-2
Scientists have developed a new technique for determining alternative structural RNA shapes of the SARS-CoV-2 virus. These self-regulatory segments of RNA, called switches, could serve as potential antiviral drug targets, according to a communication published in Nature Methods on February 22. Read More
Sanofi, GSK start phase II COVID-19 vaccine study
Sanofi and GlaxoSmithKline (GSK) are starting a large phase II study of their COVID-19 vaccine. Read More
Biohaven's antiviral antibody conjugate is effective in vitro
Biohaven Pharmaceutical's hyperimmune globulin mimic, developed on its proprietary multimodal antibody therapy enhancer platform, has demonstrated functional binding and neutralization of the SARS-CoV-2 virus, including emerging variants. Read More
Amyris, IDRI post positive preclinical results for COVID-19 vaccine
Amyris, in partnership with the Infectious Disease Research Institute (IDRI), has released preliminary data from a preclinical study of its RNA COVID-19 vaccine platform. Read More
J&J submits Janssen COVID-19 vaccine to WHO for emergency use listing
Johnson & Johnson announced it has submitted Janssen's investigational single-dose COVID-19 vaccine candidate to the World Health Organization (WHO) for emergency use listing. Read More
Novavax to supply Covax with 1.1B COVID-19 vaccine doses
Novavax announced a memorandum of understanding with Gavi, the Vaccine Alliance, to provide 1.1 billion cumulative doses of its COVID-19 vaccine candidate, NVX-CoV2373, to the Covax facility. The company has also fully enrolled participants in its pivotal phase III clinical trial of NVX-CoV2373. Read More
Thermo Fisher launches new electron microscope
Thermo Fisher Scientific has unveiled its new Helios 5 PXL Wafer DualBeam, a plasma-focused ion beam scanning electron microscope. The microscope can reduce time-to-data from days to hours for inline through-stack metrology and verify high-aspect ratio structures, the firm said. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter